Clinical Report: Reinfection with SARS-CoV-2 and Long COVID in Pediatrics

Overview

This study identifies a prevalence of long COVID at 11.8% among pediatric patients, with reinfection being a significant risk factor. The findings underscore the need for ongoing monitoring and management of long COVID symptoms in children.

Background

Long COVID represents a significant concern following acute SARS-CoV-2 infection, particularly in pediatric populations where symptoms can persist or emerge long after the initial infection. Understanding the prevalence and associated factors of long COVID in children is crucial for developing effective management strategies and improving patient outcomes.

Data Highlights

Key Findings

• The prevalence of long COVID in the studied pediatric population was found to be 11.8%.
• Common symptoms of long COVID included cough, myalgia, asthenia, and irritability.
• Reinfection with SARS-CoV-2 was identified as a significant risk factor for long COVID in children over 8 years old.
• For children under 8 years, male sex was associated with a higher risk of developing long COVID.
• These findings highlight the importance of monitoring for long COVID symptoms in pediatric patients post-infection.

Clinical Implications

Healthcare professionals should be vigilant in assessing children for long COVID symptoms, particularly in those with a history of reinfection. Early identification and management of symptoms can improve quality of life and reduce the long-term impact of these conditions.

Conclusion

The study emphasizes the need for continued research into long COVID in pediatric populations, particularly regarding the implications of reinfection. Understanding these dynamics will aid in developing targeted interventions and management strategies.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Long COVID Clinical Guidance | Long COVID | CDC
5. Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR): a retrospective cohort study - ScienceDirect
6. Functional Limitations and Illness-Related Absenteeism among School-Aged Children with and without Long COVID, United States, 2022–2023 - Volume 31, Supplement—November 2025 - Emerging Infectious Diseases journal - CDC
7. Frontiers in Pediatrics — RSV-infected children with mixed infections: clinical features and early predictive indicators of codetection with Streptococcus pneumoniae and Haemophilus influenzae
8. Long COVID Clinical Guidance | Long COVID | CDC
9. Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR): a retrospective cohort study - ScienceDirect
10. Functional Limitations and Illness-Related Absenteeism among School-Aged Children with and without Long COVID, United States, 2022–2023 - Volume 31, Supplement—November 2025 - Emerging Infectious Diseases journal - CDC